We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Acquired Biotech Products Help Big Pharma Fill Pipeline, Experts Say
Acquired Biotech Products Help Big Pharma Fill Pipeline, Experts Say
June 21, 2005
Roughly half of the products large drugmakers receive approval for today are generated from in-licensed molecules, according to an industry expert, who said drugmakers can find particularly high value in acquisitions of large-molecule biologic products.